Haas R - Search Results

1

Cell surface sialylation and ecto-sialyltransferase activity of human CD34 progenitors from peripheral blood and bone marrow.

Schwartz-Albiez R, Merling A, Martin S, Haas R, Gross HJ. Schwartz-Albiez R, et al. Among authors: haas r. Glycoconj J. 2004;21(8-9):451-9. doi: 10.1007/s10719-004-5535-5. Glycoconj J. 2004. PMID: 15750786

2

Molecular biology of hematopoietic stem cells.

Steidl U, Kronenwett R, Martin S, Haas R. Steidl U, et al. Among authors: haas r. Vitam Horm. 2003;66:1-28. doi: 10.1016/s0083-6729(03)01001-x. Vitam Horm. 2003. PMID: 12852251 Review.

3

Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content.

Voso MT, Hohaus S, Moos M, Pförsich M, Cremer FW, Schlenk RF, Martin S, Hegenbart U, Goldschmidt H, Haas R. Voso MT, et al. Among authors: haas r. Br J Haematol. 1999 Feb;104(2):382-91. doi: 10.1046/j.1365-2141.1999.01171.x. Br J Haematol. 1999. PMID: 10050723 Free article.

4

The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells.

Kronenwett R, Martin S, Haas R. Kronenwett R, et al. Among authors: haas r. Stem Cells. 2000;18(5):320-30. doi: 10.1634/stemcells.18-5-320. Stem Cells. 2000. PMID: 11007916 Review.

5

Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer.

Hohaus S, Wallwiener D, Martin S, Voso MT, Huober J, Fersis N, Bastert G, Haas R. Hohaus S, et al. Among authors: haas r. Semin Oncol. 1998 Apr;25(2 Suppl 4):7-11; discussion 45-8. Semin Oncol. 1998. PMID: 9578056 Clinical Trial.

6

Mobilization of CD34+ haematopoietic stem cells is associated with a functional inactivation of the integrin very late antigen 4.

Lichterfeld M, Martin S, Burkly L, Haas R, Kronenwett R. Lichterfeld M, et al. Among authors: haas r. Br J Haematol. 2000 Jul;110(1):71-81. doi: 10.1046/j.1365-2141.2000.02130.x. Br J Haematol. 2000. PMID: 10930981 Free article.

7

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin's lymphoma.

Moos M, Schulz R, Martin S, Benner A, Haas R. Moos M, et al. Among authors: haas r. Leukemia. 1998 Dec;12(12):1971-6. doi: 10.1038/sj.leu.2401242. Leukemia. 1998. PMID: 9844927

8

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).

Voso MT, Martin S, Hohaus S, Abdallah A, Schlenk RF, Ho AD, Haas R. Voso MT, et al. Among authors: haas r. Bone Marrow Transplant. 2000 May;25(9):957-64. doi: 10.1038/sj.bmt.1702336. Bone Marrow Transplant. 2000. PMID: 10800063

9

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

Hohaus S, Martin S, Schneeweiss A, Voso MT, Schlenk RF, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Among authors: haas r. Cancer Chemother Pharmacol. 1999;44 Suppl:S13-7. doi: 10.1007/s002800051110. Cancer Chemother Pharmacol. 1999. PMID: 10602904 Clinical Trial.

10

Tandem and triple high-dose chemotherapy with autologous stem cell rescue in metastatic breast cancer.

Huober J, Schneeweiss A, Hohaus S, Wittmann G, Meyer A, Martin S, Goldschmidt H, Bastert G, Haas R, Wallwiener D. Huober J, et al. Among authors: haas r. J Cancer Res Clin Oncol. 1998;124(12):690-4. doi: 10.1007/s004320050233. J Cancer Res Clin Oncol. 1998. PMID: 9879830 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,944 results

Search Page

Filters